Class II

Drug Recall: fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25.

Wells Pharma of Houston LLC · April 1, 2026

Reason for Recall

cGMP deviations.

Distribution

U.S. Nationwide.

States Affected

NATIONWIDE

Quantity Affected

50 syringes

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0505-2026

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.